Home > Insider Trading > Filing (0001042167-24-000042)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
863894	Veru Inc.	VERU	Pharmaceutical Preparations (2834)	391144397

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1276244	Shuster Mitchell Steiner	2916 North Miami Avenue Suite 1000 Miami FL 33127	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-05-22	6,504	$1.39	7,006,388	No	4	S	Direct
Common Stock	Disposition	2024-05-23	300	$1.35	7,006,088	No	4	S	Direct
Common Stock	Disposition	2024-05-24	63,379	$1.23	6,942,709	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	144,000	Indirect	Footnote

Footnotes

Dr. Steiner sold the shares referenced above to help address certain personal matters. The sold shares represent only 0.7% of Dr. Steiner's total beneficial ownership in the Company. After these sales, Dr. Steiner will beneficially own 9,615,996 shares, and will continue to be the Company's second largest shareholder.
The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.38 to $1.40. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.
The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.22 to $1.27. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.
Shares are held by four individual trusts with each trust for the benefit of an adult child of the reporting person. The reporting person is the trustee of each of the trusts. The reporting person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.